TrialClinical cancer research : an official journal of the American Association for Cancer Research2013

Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection.

Fiona Collinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.